- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/72 - Nitrogen atoms
Patent holdings for IPC class C07D 213/72
Total number of patents in this class: 271
10-year publication summary
|
13
|
17
|
18
|
15
|
7
|
10
|
14
|
15
|
13
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Boehringer Ingelheim International GmbH | 4632 |
12 |
| UCB Biopharma SRL | 582 |
11 |
| Tetra Discovery Partners, LLC | 11 |
9 |
| Corteva Agriscience LLC | 2703 |
9 |
| Arvinas Operations, Inc. | 241 |
7 |
| Bayer Pharma AG | 1054 |
6 |
| Ishihara Sangyo Kaisha, Ltd. | 665 |
5 |
| Bristol-myers Squibb Company | 4847 |
4 |
| The Regents of the University of California | 20195 |
4 |
| Vertex Pharmaceuticals Incorporated | 1627 |
4 |
| Emory University | 1646 |
4 |
| Sloan-Kettering Institute for Cancer Research | 535 |
4 |
| Medivation Technologies LLC | 21 |
4 |
| Merck Sharp & Dohme LLC | 3737 |
4 |
| Merck Sharp & Dohme Corp. | 2190 |
3 |
| Dong Wha Pharm. Co., Ltd. | 52 |
3 |
| Medshine Discovery Inc. | 598 |
3 |
| The Scripps Research Institute | 1354 |
3 |
| Shionogi & Co., Ltd. | 839 |
3 |
| Alumis Inc. | 31 |
3 |
| Other owners | 166 |